From The

Media

OCON Therapeutics Secures $10M in Funding to Revolutionize Women’s Health with Advanced Drug Delivery Solutions

June 24, 2024

|

Femtech Insider

OCON Therapeutics has been awarded the 2024 Seal of Excellence from the EU Commission – recognizing top-tier innovative ideas worthy of investment – for its IUB® Platform’s innovative nature and potential to drive meaningful change for women and families in the EU and globally.

April 3, 2024

|

EU Commission

OCON Therapeutics contributed to the World Economic Forum and McKinsey Health Institute’s report, “Closing the Women’s Health Gap: A $1 Trillion Opportunity to Improve Lives and Economies.”

January 17, 2024

|

World Economic Forum

OCON Therapeutics has reached its recruitment goal of its Phase IIb clinical study evaluating the revolutionary IUB® SEAD®, a non-invasive treatment for heavy menstrual bleeding affecting 1 in 3 women

March 24, 2023

|

Femtechworld